Search research articles
Contact Us
Filters
Showing results (121-130 of 136) with videos related to
Page
of 14
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
November 2, 2016
Discovery of selective small-molecule HDAC6 inhibitor for overcoming proteasome inhibitor resistance in multiple myeloma
Teru Hideshima, Jun Qi, Ronald M Paranal, et al.
Nature Chemical Biology
|
May 28, 2026
Pharmacological targeting of IRF4 as a therapeutic strategy for multiple myeloma
Michael P Agius, Chen Song, Qi Liu, et al.
Biorxiv : the Preprint Server for Biology
|
May 27, 2024
KBTBD4 Cancer Hotspot Mutations Drive Neomorphic Degradation of HDAC1/2 Corepressor Complexes
Xiaowen Xie, Olivia Zhang, Megan J R Yeo, et al.
Chemistry & Biology
|
December 27, 2011
Identification and validation of tetracyclic benzothiazepines as Plasmodium falciparum cytochrome bc1 inhibitors
Carolyn K Dong, Sameer Urgaonkar, Joseph F Cortese, et al.
Nature
|
February 12, 2025
Converging mechanism of UM171 and KBTBD4 neomorphic cancer mutations
Xiaowen Xie, Olivia Zhang, Megan J R Yeo, et al.
Cell Reports Methods
|
April 14, 2023
Diagnostic TR-FRET assays for detection of antibodies in patient samples
Hong Yue, Radosław P Nowak, Daan Overwijn, et al.
Science Translational Medicine
|
May 22, 2015
The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs
Jonathan D Herman, Lauren R Pepper, Joseph F Cortese, et al.
Biorxiv : the Preprint Server for Biology
|
May 27, 2024
Asymmetric Engagement of Dimeric CRL3 <sup>KBTBD4</sup> by the Molecular Glue UM171 Licenses Degradation of HDAC1/2 Complexes
Megan Jr Yeo, Olivia Zhang, Xiaowen Xie, et al.
Blood Cancer Journal
|
February 6, 2023
Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma
Keiji Kurata, Anna James-Bott, Mark A Tye, et al.
Blood Cancer Journal
|
January 11, 2023
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma
Keiji Kurata, Anna James-Bott, Mark A Tye, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 136) with videos related to
Sort By:
Page
of 14
Proceedings of the National Academy of Sciences of the United States of America
|
November 2, 2016
Discovery of selective small-molecule HDAC6 inhibitor for overcoming proteasome inhibitor resistance in multiple myeloma
Teru Hideshima, Jun Qi, Ronald M Paranal, et al.
Nature Chemical Biology
|
May 28, 2026
Pharmacological targeting of IRF4 as a therapeutic strategy for multiple myeloma
Michael P Agius, Chen Song, Qi Liu, et al.
Biorxiv : the Preprint Server for Biology
|
May 27, 2024
KBTBD4 Cancer Hotspot Mutations Drive Neomorphic Degradation of HDAC1/2 Corepressor Complexes
Xiaowen Xie, Olivia Zhang, Megan J R Yeo, et al.
Chemistry & Biology
|
December 27, 2011
Identification and validation of tetracyclic benzothiazepines as Plasmodium falciparum cytochrome bc1 inhibitors
Carolyn K Dong, Sameer Urgaonkar, Joseph F Cortese, et al.
Nature
|
February 12, 2025
Converging mechanism of UM171 and KBTBD4 neomorphic cancer mutations
Xiaowen Xie, Olivia Zhang, Megan J R Yeo, et al.
Cell Reports Methods
|
April 14, 2023
Diagnostic TR-FRET assays for detection of antibodies in patient samples
Hong Yue, Radosław P Nowak, Daan Overwijn, et al.
Science Translational Medicine
|
May 22, 2015
The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs
Jonathan D Herman, Lauren R Pepper, Joseph F Cortese, et al.
Biorxiv : the Preprint Server for Biology
|
May 27, 2024
Asymmetric Engagement of Dimeric CRL3 <sup>KBTBD4</sup> by the Molecular Glue UM171 Licenses Degradation of HDAC1/2 Complexes
Megan Jr Yeo, Olivia Zhang, Xiaowen Xie, et al.
Blood Cancer Journal
|
February 6, 2023
Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma
Keiji Kurata, Anna James-Bott, Mark A Tye, et al.
Blood Cancer Journal
|
January 11, 2023
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma
Keiji Kurata, Anna James-Bott, Mark A Tye, et al.
Page
of 14